Testing begins on potential antibody drug cocktail for COVID-19

AstraZeneca is starting Phase 1 trials of a potential antibody treatment for the coronavirus. Dr. Dyan Hes joins CBSN to discuss that, plus the FDA's controversial move to approve emergency use of convalescent plasma.